Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Nina Sehnke, Ingmar Bruns, MD, Akos Czibere, MD, Fabian Zohren, Nancy Safaian, Ariane Dienst, Leilani Ruf, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD, Guido Kobbe, MD

Blood (2007) 110 (11): 1496.

https://doi.org/10.1182/blood.V110.11.1496.1496

Published: 2007

Journal Articles

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Ingmar Bruns, MD, Johannes C. Fischer, MD, Akos G. Czibere, MD, Cangül Kilic, Roland Fenk, MD, Fabian Zohren, MD, Ralf Kronenwett, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2007) 110 (11): 4920.

https://doi.org/10.1182/blood.V110.11.4920.4920

Published: 2007

Journal Articles

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Ingmar Bruns, MD, Akos G. Czibere, MD, Johannes C. Fischer, MD, Ulrich Steidl, MD, PhD, Sabrina Pechtel, Annemarie Koch, Daniela Brünnert, Sebastian Büst, Ron-Patrick Cadeddu, Ralf Kronenwett, MD, Rainer Haas, MD

Blood (2007) 110 (11): 3170.

https://doi.org/10.1182/blood.V110.11.3170.3170

Published: 2007

Journal Articles

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

Frank Neumann, MD, Daniela C. Bruennert, Anne-Marie Koch, Ingmar Bruns, MD, Norbert Gattermann, MD, PhD, Ralf Kronenwett, MD, PhD, Rainer Haas, MD, PhD

Blood (2007) 110 (11): 4540.

https://doi.org/10.1182/blood.V110.11.4540.4540

Published: 2007

Journal Articles

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Ralf Kronenwett, MD, Elena Diaz-Blanco, Thorsten Graef, MD, Ulrich Steidl, MD, Slawomir Kliszewski, Ingmar Bruns, Frank Neumann, MD, Simone Bork, Ulf Butterweck, Nicole Roes, Benedikt Brors, PhD, Roland Eils, PhD, Guido Kobbe, MD, Norbert Gattermann, MD, Rainer Haas, MD

Blood (2005) 106 (11): 2863.

https://doi.org/10.1182/blood.V106.11.2863.2863

Published: 2005

Journal Articles

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Guido Kobbe, MD, Roland Fenk, MD, Slawomir Kliszewski, Sabrina Pechtel, Rainer Haas, MD, PhD, Ralf Kronenwett, MD, PhD

Blood (2005) 106 (11): 5191.

https://doi.org/10.1182/blood.V106.11.5191.5191

Published: 2005

Journal Articles

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Guido Kobbe, MD, Ulrich Steidl, MD, Thorsten Graef, MD, Ulrich-Peter Rohr, MD, Leilani Ruf, MD, Barbara Hoyer, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2004) 104 (11): 4871.

https://doi.org/10.1182/blood.V104.11.4871.4871

Published: 2004

NARROW

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only